Disclosure Quest - Search SEC Filings

More options

Type of Offering

Amount To Be Raised

to

Filing Date

to

Type of Security

Industry

CIK Number

Principal Place Of Business

Found 5 results

Name	Type of Offering	Accepted Date
Briotech Inc. See All Filings	D	2021-08-25 15:30:11 UTC
Amount To Be Raised $11,000,000 Associated Brokers / Dealers N/A CIK Number 0001682992 Filed Document 0001682992-21-000001 Exclusions or Exemptions 506b Accepted Date 2021-08-25 15:30:11 UTC Type of Offering D Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Equity
Briotech Inc. See All Filings	D	2020-10-28 15:20:51 UTC
Amount To Be Raised $1,500,000 Associated Brokers / Dealers N/A CIK Number 0001682992 Filed Document 0001682992-20-000003 Exclusions or Exemptions 506b Accepted Date 2020-10-28 15:20:51 UTC Type of Offering D Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Other
Briotech Inc. See All Filings	D/A	2017-05-02 12:14:05 UTC
Amount To Be Raised $700,000 Associated Brokers / Dealers N/A CIK Number 0001682992 Filed Document 0001682992-17-000001 Exclusions or Exemptions 506b Accepted Date 2017-05-02 12:14:05 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Equity
Briotech Inc. See All Filings	D/A	2016-12-19 19:27:54 UTC
Amount To Be Raised $450,000 Associated Brokers / Dealers N/A CIK Number 0001682992 Filed Document 0001682992-16-000002 Exclusions or Exemptions 506b Accepted Date 2016-12-19 19:27:54 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Equity
Briotech Inc. See All Filings	D	2016-08-24 14:57:55 UTC
Amount To Be Raised $350,000 Associated Brokers / Dealers N/A CIK Number 0001682992 Filed Document 0001682992-16-000001 Exclusions or Exemptions 506b Accepted Date 2016-08-24 14:57:55 UTC Type of Offering D Industry Biotechnology Principal Place of Business WASHINGTON Revenue or Assets Decline to Disclose Type of Security Equity